Increased Expression of Toll-like Receptor (TLR) 2 and TLR4 in the Colonic Mucosa of Children with Inflammatory Bowel Disease

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2007 Nov 10

PMID 17991289

Citations 78

Authors

B Szebeni

G Veres

A Dezsofi

K Rusai

A Vannay

M Mraz

E Majorova

A Arato

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) may result from exaggerated stimulation of the mucosal immune system by luminal bacterial flora. Bacterial products are recognized by pattern recognition receptors such as Toll-like receptors (TLRs), which are key regulators of the innate immune system. Therefore, the expression of TLR2, TLR3 and TLR4 in colonic biopsy samples taken from children with active IBD were studied and compared to controls. Colonic biopsy samples were collected from macroscopically inflamed and non-inflamed regions of the mucosa of 12 children with freshly diagnosed IBD (fdIBD) and 23 children with relapsed IBD (rIBD). Specimens were also obtained from eight controls. TLR2, TLR3 and TLR4 mRNA expression and protein levels were determined by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot. We found higher TLR2 and TLR4 mRNA and protein levels in the inflamed colonic mucosa of children with fdIBD and rIBD compared to controls. In the non-inflamed colonic mucosa of children with fdIBD and rIBD, TLR2 and TLR4 mRNA and protein levels were similar to controls. TLR2 and TLR4 mRNA and protein levels also did not differ between children with fdIBD or rIBD in either inflamed or non-inflamed colonic mucosa. TLR3 mRNA expression and protein levels were similar in all groups studied. Our results of increased levels of TLR2 and TLR4 in the inflamed colonic mucosa of children with IBD confirm the hypothesis that innate immunity has an important role in the pathogenesis of this disease.

Citing Articles

Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue.

Bosakova V, Papatheodorou I, Kafka F, Tomasikova Z, Kolovos P, Hortova Kohoutkova M Exp Mol Med. 2025; 57(2):364-378.

PMID: 39894823 PMC: 11873120. DOI: 10.1038/s12276-025-01397-1.

A New Probiotic Formulation Promotes Resolution of Inflammation in a Crohn's Disease Mouse Model by Inducing Apoptosis in Mucosal Innate Immune Cells.

De Salvo C, Osme A, Ghannoum M, Cominelli F, Di Martino L Int J Mol Sci. 2024; 25(22).

PMID: 39596135 PMC: 11593709. DOI: 10.3390/ijms252212066.

Mechanistic insight of neurodegeneration due to micro/nano-plastic-induced gut dysbiosis.

Ghosh A, Gorain B Arch Toxicol. 2024; 99(1):83-101.

PMID: 39370473 DOI: 10.1007/s00204-024-03875-3.

Deciphering internal and external factors influencing intestinal junctional complexes.

Markovich Z, Abreu A, Sheng Y, Han S, Xiao R Gut Microbes. 2024; 16(1):2389320.

PMID: 39150987 PMC: 11332634. DOI: 10.1080/19490976.2024.2389320.

Protective effect of Cordycepin on blood-testis barrier against pre-puberty polystyrene nanoplastics exposure in male rats.

Hu Y, Jiang S, Zhang Q, Zhou W, Liang J, Xu Y Part Fibre Toxicol. 2024; 21(1):30.

PMID: 39118174 PMC: 11312894. DOI: 10.1186/s12989-024-00590-w.

References

Battaglia E, Biancone L, Resegotti A, Emanuelli G, Fronda G, Camussi G . Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol. 1999; 94(11):3279-84. DOI: 10.1111/j.1572-0241.1999.01538.x. View

Cario E . Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut. 2005; 54(8):1182-93. PMC: 1774880. DOI: 10.1136/gut.2004.062794. View

Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R . Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12(9):885-913. DOI: 10.1097/01.mib.0000228358.25364.8b. View

Schultsz C, van den Berg F, ten Kate F, Tytgat G, Dankert J . The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117(5):1089-97. DOI: 10.1016/s0016-5085(99)70393-8. View

Cario E, Podolsky D . Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol Immunol. 2005; 42(8):887-93. DOI: 10.1016/j.molimm.2004.12.002. View

Mayer L, Eisenhardt D, Salomon P, BAUER W, Plous R, Piccinini L . Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology. 1991; 100(1):3-12. DOI: 10.1016/0016-5085(91)90575-6. View

Polese L, Angriman I, Cecchetto A, Norberto L, Scarpa M, Ruffolo C . The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol. 2002; 14(3):237-41. DOI: 10.1097/00042737-200203000-00006. View

McDyer J, Dybul M, Goletz T, Kinter A, Thomas E, Berzofsky J . Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. J Immunol. 1999; 162(6):3711-7. View

Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M . Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003; 15(6):721-30. DOI: 10.1093/intimm/dxg068. View

10.

Linskens R, Huijsdens X, Savelkoul P, Vandenbroucke-Grauls C, Meuwissen S . The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl. 2002; (234):29-40. DOI: 10.1080/003655201753265082. View

11.

Sellon R, Tonkonogy S, Schultz M, Dieleman L, Grenther W, Balish E . Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66(11):5224-31. PMC: 108652. DOI: 10.1128/IAI.66.11.5224-5231.1998. View

12.

Fuss I, Neurath M, Boirivant M, Klein J, de La Motte C, Strong S . Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157(3):1261-70. View

13.

Hilsden R, Meddings J, Sutherland L . Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology. 1996; 110(5):1395-403. DOI: 10.1053/gast.1996.v110.pm8613043. View

14.

Macdonald T, Monteleone G . Immunity, inflammation, and allergy in the gut. Science. 2005; 307(5717):1920-5. DOI: 10.1126/science.1106442. View

15.

Cario E, Gerken G, Podolsky D . Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004; 127(1):224-38. DOI: 10.1053/j.gastro.2004.04.015. View

16.

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

17.

Medzhitov R . Toll-like receptors and innate immunity. Nat Rev Immunol. 2002; 1(2):135-45. DOI: 10.1038/35100529. View

18.

Meylan E, Tschopp J . Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell. 2006; 22(5):561-9. DOI: 10.1016/j.molcel.2006.05.012. View

19.

Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L . Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997; 150(3):823-32. PMC: 1857889. View

20.

Hart A, Al-Hassi H, Rigby R, Bell S, Emmanuel A, Knight S . Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005; 129(1):50-65. DOI: 10.1053/j.gastro.2005.05.013. View